Harel Insurance Investments & Financial Services’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
GIPM
AC
AIC
FLAM
CS
Harel Insurance Investments & Financial Services's OPRX Position: Q4 2022 in Review
Harel Insurance Investments & Financial Services sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 284 shares — an estimated $4K sold.
Harel Insurance Investments & Financial Services first reported a position in OPRX in Q3 2020 and held it in 7 quarters. The position peaked at $991K in Q1 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.
- Harel Insurance Investments & Financial Services reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 284 OptimizeRx shares in Q4 2022, an estimated $4K.
- Harel Insurance Investments & Financial Services first reported a position in OptimizeRx in Q3 2020 and held it in 7 quarters.
- Harel Insurance Investments & Financial Services's OptimizeRx position peaked at $991K in Q1 2021.
- 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2022, filed 26 Jan 2023.